English | Español
Patient Daily | Dec 9, 2025

FDA’s advanced manufacturing designation may ease mid-development process changes for cell therapies
Patient Daily | Dec 9, 2025

Lilly reduces Zepbound prices amid ongoing competition with Novo Nordisk
Patient Daily | Dec 9, 2025

FDA official links child deaths to COVID-19 vaccines and proposes stricter review process
Patient Daily | Dec 9, 2025

Study finds rising rates of adolescent noise-induced hearing damage by age eighteen
Patient Daily | Dec 9, 2025

How data bias affects growth marketing strategies
Patient Daily | Dec 9, 2025

UK agrees to pay more for drugs in exchange for tariff exemption
Patient Daily | Dec 9, 2025

UTHealth Houston surgeon treats rare facial pain disorder for El Paso woman
Patient Daily | Dec 8, 2025

Rare disease experts urge consistent FDA policies amid mixed approvals

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug